Overcoming multidrug resistance(MDR) in cancer by nanotechnology

被引：0
|
作者：
BU HuiHui
机构：
来源：
Science China Chemistry | 2010年 / 53卷 / 11期
基金：
中国国家自然科学基金;
关键词：
nanotechnology; nanoparticles; multidrug resistance; chemotherapeutic drugs; cancer; drug delivery system;
D O I：
暂无
中图分类号：
R319 [其他科学技术在医学上的应用];
学科分类号：
1001 ;
摘要：
The emerging nanotechnology-based drug delivery holds tremendous potential to deliver chemotherapeutic drugs for treatment of multidrug resistance(MDR) cancer.This drug delivery system could improve the pharmacokinetic behavior of antitumor drugs,deliver chemotherapeutic drugs to target sites,control release of drugs,and reduce the systemic toxicity of drugs in MDR cancer.This review addresses the use of nanotechnology to overcome MDR classified on the bases of the fundamental mechanisms of MDR and various approaches to deliver drugs for treatment of MDR cancer.
引用
收藏
页码：2226 / 2232
页数：7
相关论文
共 50 条
  • [1] Overcoming multidrug resistance (MDR) in cancer by nanotechnology
    Bu HuiHui
    Gao Yu
    Li YaPing
    [J]. SCIENCE CHINA-CHEMISTRY, 2010, 53 (11) : 2226 - 2232
  • [2] Overcoming multidrug resistance (MDR) in cancer by nanotechnology
    HuiHui Bu
    Yu Gao
    YaPing Li
    [J]. Science China Chemistry, 2010, 53 : 2226 - 2232
  • [3] Role of Nanotechnology in Overcoming the Multidrug Resistance in Cancer Therapy: A Review
    Mir, Suhail Ahmad
    Hamid, Laraibah
    Bader, Ghulam Nabi
    Shoaib, Ambreen
    Rahamathulla, Mohamed
    Alshahrani, Mohammad Y.
    Alam, Prawez
    Shakeel, Faiyaz
    [J]. MOLECULES, 2022, 27 (19):
  • [4] Overcoming multidrug resistance (MDR) in cancer in vitro and in vivo by a quinoline derivative
    Ganguly, Avishek
    Banerjee, Kaushik
    Chakraborty, Paramita
    Das, Satyajit
    Sarkar, Avijit
    Hazra, Abhijit
    Banerjee, Maitrayee
    Maity, Arindam
    Chatterjee, Mitali
    Mondal, Nirup B.
    Choudhuri, Soumitra Kumar
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2011, 65 (06) : 387 - 394
  • [5] Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology
    Xue, Xue
    Liang, Xing-Jie
    [J]. CHINESE JOURNAL OF CANCER, 2012, 31 (02) : 100 - 109
  • [6] Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology
    Xue Xue and Xing-Jie Liang CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety
    [J]. 癌症, 2012, 31 (02) : 100 - 109
  • [7] Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons
    Majidinia, Maryam
    Mirza-Aghazadeh-Attari, Mohammad
    Rahimi, Mahdi
    Mihanfar, Ainaz
    Karimian, Ansar
    Safa, Amin
    Yousefi, Bahman
    [J]. IUBMB LIFE, 2020, 72 (05) : 855 - 871
  • [8] An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy
    Takara, K
    Sakaeda, T
    Okumura, K
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (03) : 273 - 286
  • [9] OVERCOMING MULTIDRUG RESISTANCE (MDR) BY RNA INTERFERENCE (RNAi) TECHNOLOGY
    Lage, Hermann
    [J]. ANTICANCER RESEARCH, 2004, 24 (5D) : 3546 - 3546
  • [10] Overcoming multidrug resistance (MDR) in colorectal cancer by modulating exosome-mediated transfer of MDR transporter regulatory machineries
    To, Kenneth K. W.
    Tong, Christy W. S.
    Wu, Mia M. X.
    Yan, Wei
    [J]. CANCER RESEARCH, 2019, 79 (13)
12345